ENDOUROLOGY - Original Article

Clinical Outcomes of Prostatic Artery Embolization in Patients with Benign Prostatic Hyperplasia: A Prospective Clinical Study

Volume 48 · Issue 3 Publish Date: May 16, 2022
Full Text PDF
DOI
Kazım Dogan
Department of Urology, LIV Hospital, Gaziantep Turkey
Ahmet Erbagci
Department of Urology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
Haluk Sen
Department of Urology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
Selim Kervancioglu
Department of Urology, Sanko University Faculty of Medicine, Gaziantep, Turkey
Mehmet Sakıp Erturhan
Department of Urology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
İlker Seckiner
Department of Urology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
Ömer Bayrak
Department of Urology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
Dogan, K., Erbagci, A., Sen, H., Kervancioglu, S., Erturhan, M. S., Seckiner, İlker, & Bayrak, Ömer. (2022). Clinical Outcomes of Prostatic Artery Embolization in Patients with Benign Prostatic Hyperplasia: A Prospective Clinical Study. Urology Research and Practice, 48(3), 215–221. https://doi.org/10.5152/tud.2022.22004
Full Text Full Text PDF

Abstract

Objective: To determine the clinical outcomes of prostatic artery embolization applied to patients with

Material and methods: The study includes 30 patients diagnosed with benign prostatic hyperplasia in the urology clinic between 2012 and 2016, for whom anesthesia was contraindicated due to advanced age and comorbidities and who underwent prostatic artery embolization. These patients were evaluated before the procedure and in the 1st, 3rd, 6th, and 12th months after the procedure.

Results: The mean prostate volume of the patients was 68 cm3 before the procedure and 45 cm3 12 monthsafter the procedure. A statistically significant decrease was observed (P = .001). The mean prostate-specific antigen value was 4.9 ng/dL before the procedure and 2.8 ng/dL 12 months after the procedure (P = .008). The mean Qmax value was 0 mL/s before the procedure and 12 mL/s 12 months after the procedure (P = .001). The mean international prostatic symptom scores value was 35 before and 16 twelve months after the proce-dure (P = .001). While the international index of erectile function value was 8.25 before the procedure, it was8.46 12 months after the procedure (P = .32). The quality of life index value was measured as 3.02 before theprocedure and 3.09 twelve months after the procedure; a statistically significant difference was determined (P = .027).

Conclusion: Prostatic artery embolization, which is a minimally invasive procedure, can be applied as a safe and effective method to patients with benign prostatic hyperplasia who cannot tolerate anesthesia due to advanced age and comorbidities.

Cite this article as: Dogan K, Erbagci A, Sen H, et al. Clinical outcomes of prostatic artery embolization in patients with benignprostatic hyperplasia: A prospective clinical study. Turk J Urol. 2022;48(3):215-221.

Similar Articles

Article Info
Published In
Journal Urology Research and Practice
Volume / Issue Volume 48 · Issue 3
Pages 215-221
History
Published Online May 16, 2022
Copyright
Affiliations
Kazım Dogan
Department of Urology, LIV Hospital, Gaziantep Turkey
Ahmet Erbagci
Department of Urology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
Haluk Sen
Department of Urology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
Selim Kervancioglu
Department of Urology, Sanko University Faculty of Medicine, Gaziantep, Turkey
Mehmet Sakıp Erturhan
Department of Urology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
İlker Seckiner
Department of Urology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
Ömer Bayrak
Department of Urology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
Cite this Article
Dogan, K., Erbagci, A., Sen, H., Kervancioglu, S., Erturhan, M. S., Seckiner, İlker, & Bayrak, Ömer. (2022). Clinical Outcomes of Prostatic Artery Embolization in Patients with Benign Prostatic Hyperplasia: A Prospective Clinical Study. Urology Research and Practice, 48(3), 215–221. https://doi.org/10.5152/tud.2022.22004
Outlines